Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck drug triggers response in 24 pct of lung cancer patients
Merck drug triggers response in 24 pct of lung cancer patients
Merck drug triggers response in 24 pct of lung cancer patients
Submitted by
admin
on October 1, 2013 - 6:04pm
Source:
Yahoo/Reuters
News Tags:
Merck
MK-3475
lung cancer
Headline:
Merck drug triggers response in 24 pct of lung cancer patients
Do Not Allow Advertisers to Use My Personal information
